SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys stock buybacks 1990–2026

Synopsys spent 37.50M USD buying back its shares in Q3 FY2026, the three months to 31 July 2026, down 72.8% on the same quarter a year before. Synopsys spent 0.00 USD buying back its shares in fiscal year 2025, with no change to compare on the year before.

Last updated 6 Nov 2026 · Next report 8 Dec 2026

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM31 Jul 2026———2.79B
FY202531 Oct 20250.00—0.001.35B
FY202431 Oct 20240.00-100.00%0.001.28B
FY202331 Oct 20231.16B+5.52%0.001.51B
FY202231 Oct 20221.10B+46.07%0.001.60B
FY202131 Oct 2021753.08M+211.09%0.001.40B
FY202031 Oct 2020242.08M-26.46%0.00832.55M
FY201931 Oct 2019329.19M-17.70%0.00598.13M
FY201831 Oct 2018400.00M+5.26%0.00322.31M
FY201731 Oct 2017380.00M-5.00%0.00561.01M
FY201631 Oct 2016400.00M+53.85%0.00515.60M
FY201531 Oct 2015260.00M+117.12%0.00404.51M
FY201431 Oct 2014119.75M-17.42%0.00444.04M
FY201331 Oct 2013145.02M+262.54%0.00427.64M
FY201231 Oct 201240.00M-90.05%0.00428.58M
FY201131 Oct 2011401.84M+117.56%0.00380.09M
FY201031 Oct 2010184.70M—0.00298.96M
FY200931 Oct 20090.00-100.00%0.00197.11M
FY200831 Oct 2008220.05M+45.13%0.00289.35M
FY200731 Oct 2007151.62M-24.19%0.00386.19M
FY200631 Oct 2006199.99M+126.27%0.00154.48M
FY200531 Oct 200588.39M-79.12%0.00225.63M
FY200431 Oct 2004423.30M+62.34%0.00219.03M
FY200331 Oct 2003260.75M+51.88%0.00341.39M
FY200231 Oct 2002171.68M-48.27%0.00-229.80M
FY200131 Oct 2001331.88M-16.50%0.00213.34M
FY200031 Oct 2000397.47M+316.63%0.0082.62M
FY199930 Sept 199995.40M+669.35%0.00111.00M
FY199830 Sept 199812.40M+30.53%0.0055.70M
FY199730 Sept 19979.50M-35.81%0.0055.10M
FY199630 Sept 199614.80M—0.0049.00M
FY199530 Sept 19950.00—0.0055.80M
FY199430 Sept 19940.00—0.0042.20M
FY199330 Sept 19930.00—0.0037.50M
FY199230 Sept 19920.00—0.0013.00M
FY199130 Sept 19910.00—0.002.20M
FY199030 Sept 19900.00—0.004.90M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about Synopsys's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.